Literature DB >> 26322673

Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.

Sharon Kapambwe1, Vikrant V Sahasrabuddhe, Meridith Blevins, Mulindi H Mwanahamuntu, Victor Mudenda, Bryan E Shepherd, Carla J Chibwesha, Krista S Pfaendler, Michael L Hicks, Sten H Vermund, Jeffrey S A Stringer, Groesbeck P Parham.   

Abstract

BACKGROUND: Cervical cancer screening efforts linked to HIV/AIDS care programs are being expanded across sub-Saharan Africa. Evidence on the age distribution and determinants of invasive cervical cancer (ICC) cases detected in such programs is limited.
METHODS: We analyzed program operations data from the Cervical Cancer Prevention Program in Zambia, the largest public sector programs of its kind in sub-Saharan Africa. We examined age distribution patterns by HIV serostatus of histologically confirmed ICC cases and used multivariable logistic regression to evaluate independent risk factors for ICC among younger (≤35 years) and older (>35 years) women.
RESULTS: Between January 2006 and April 2010, of 48,626 women undergoing screening, 571 (1.2%) were diagnosed with ICC, including 262 (46%) HIV seropositive (median age: 35 years), 131 (23%) HIV seronegative (median age: 40 years), and 178 (31%) of unknown HIV serostatus (median age: 38 years). Among younger (≤35 years) women, being HIV seropositive was associated with a 4-fold higher risk of ICC [adjusted odds ratio = 4.1 (95% confidence interval: 2.8, 5.9)] than being HIV seronegative. The risk of ICC increased with increasing age among HIV-seronegative women and women with unknown HIV serostatus, but among HIV-seropositive women, the risk peaked around age 35 and nonsignificantly declined with increasing ages. Other factors related to ICC included being married (vs. being unmarried/widowed) in both younger and older women, and with having 2+ (vs. ≤1) lifetime sexual partners among younger women.
CONCLUSIONS: HIV infection seems to have increased the risk of cervical cancer among younger women in Zambia, pointing to the urgent need for expanding targeted screening interventions.

Entities:  

Mesh:

Year:  2015        PMID: 26322673      PMCID: PMC4791059          DOI: 10.1097/QAI.0000000000000685

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  27 in total

1.  An overview of the diagnosis and management of prostate cancer in Nigeria: experience from a north-central state of Nigeria.

Authors:  Kasonde Bowa
Journal:  Ann Afr Med       Date:  2010 Jul-Sep

2.  HIV infection among Uganda women with cervical cancer: a retrospective study.

Authors:  Wilberforce Kigongo Sekirime; Ron Gray
Journal:  Gynecol Obstet Invest       Date:  2006-12-22       Impact factor: 2.031

Review 3.  HIV and cancer of the cervix.

Authors:  Z M Chirenje
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2005-04       Impact factor: 5.237

4.  HIV and cervical cancer in Kenya.

Authors:  P Gichangi; H De Vuyst; B Estambale; K Rogo; J Bwayo; M Temmerman
Journal:  Int J Gynaecol Obstet       Date:  2002-01       Impact factor: 3.561

5.  Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness.

Authors:  Groesbeck P Parham; Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Andrew O Westfall; Kristin E King; Carla Chibwesha; Krista S Pfaendler; Gracilia Mkumba; Victor Mudenda; Sharon Kapambwe; Sten H Vermund; Michael L Hicks; Jeffrey Sa Stringer; Benjamin H Chi
Journal:  HIV Ther       Date:  2010

6.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

7.  The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research.

Authors:  Lara F Bratcher; Vikrant V Sahasrabuddhe
Journal:  Infect Agent Cancer       Date:  2010-05-12       Impact factor: 2.965

8.  HIV infection as a risk factor for cervical cancer and cervical intraepithelial neoplasia in Senegal.

Authors:  Rebecca S Holmes; Stephen E Hawes; Papa Touré; Ahmadou Dem; Qinghua Feng; Noel S Weiss; Nancy B Kiviat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

9.  Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy.

Authors:  Silvia Franceschi; Harold Jaffe
Journal:  Clin Infect Dis       Date:  2007-07-05       Impact factor: 9.079

Review 10.  The increasing burden of HIV-associated malignancies in resource-limited regions.

Authors:  Corey Casper
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

View more
  11 in total

Review 1.  HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities.

Authors:  Lameck Chinula; Agnes Moses; Satish Gopal
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

Review 2.  Mapping Evidence on the Burden of Breast, Cervical, and Prostate Cancers in Sub-Saharan Africa: A Scoping Review.

Authors:  Alfred Musekiwa; Maureen Moyo; Mohanad Mohammed; Zvifadzo Matsena-Zingoni; Halima Sumayya Twabi; Jesca Mercy Batidzirai; Geoffrey Chiyuzga Singini; Kabelo Kgarosi; Nobuhle Mchunu; Portia Nevhungoni; Patricia Silinda; Theodora Ekwomadu; Innocent Maposa
Journal:  Front Public Health       Date:  2022-06-16

Review 3.  Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.

Authors:  Emily S Wu; Jose Jeronimo; Sarah Feldman
Journal:  J Glob Oncol       Date:  2017-05-11

4.  Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.

Authors:  Heather A Cubie; Christine Campbell
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec

5.  Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.

Authors:  Jonah Musa; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Patrick H Daru; Lifang Hou; Robert L Murphy; Isaac F Adewole; Melissa A Simon
Journal:  BMC Health Serv Res       Date:  2018-11-22       Impact factor: 2.655

6.  Association of HIV status and treatment characteristics with VIA screening outcomes in Malawi: A retrospective analysis.

Authors:  Samuel Lewis; Misheck Mphande; Florence Chibwana; Temwa Gumbo; Ben Allan Banda; Hitler Sigauke; Agnes Moses; Sundeep Gupta; Risa M Hoffman; Corrina Moucheraud
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

7.  The Pattern of Cervical Cancer according to HIV Status in Yaoundé, Cameroon.

Authors:  Pierre-Marie Tebeu; Jean Pierre Ngou-Mve-Ngou; Laure Leka Zingué; Jesse Saint Saba Antaon; Etienne Okobalemba Atenguena; Julius Sama Dohbit
Journal:  Obstet Gynecol Int       Date:  2021-10-13

8.  Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.

Authors:  Christine Campbell; Savel Kafwafwa; Hilary Brown; Graeme Walker; Belito Madetsa; Miriam Deeny; Beatrice Kabota; David Morton; Reynier Ter Haar; Liz Grant; Heather A Cubie
Journal:  Int J Cancer       Date:  2016-05-04       Impact factor: 7.396

9.  HIV and development of epithelial cell abnormalities in women with prior normal cervical cytology in Nigeria.

Authors:  Jonah Musa; Supriya D Mehta; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Francis A Magaji; Victor C Pam; Patrick H Daru; Olugbenga A Silas; Atiene S Sagay; Rose Anorlu; Yinan Zheng; Mamoudou Maiga; Isaac F Adewole; Robert L Murphy; Lifang Hou; Melissa A Simon
Journal:  Infect Agent Cancer       Date:  2020-07-29       Impact factor: 2.965

10.  HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis.

Authors:  Jonah Musa; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Patrick H Daru; Olugbenga Silas; Atiene S Sagay; Rose Anorlu; Supriya D Mehta; Firas Wehbe; Melissa A Simon; Isaac F Adewole; Lifang Hou; Robert L Murphy
Journal:  Infect Agent Cancer       Date:  2019-11-29       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.